By Admin at 13 Oct 2017

When Carol Ramnarine was diagnosed with multiple myeloma, a rare cancer of plasma cells (a type of white blood cell in bone marrow), she was offered the chance to take part in a clinical trial run by Dr. Jeffrey Wong at City of Hope cancer treatment and research center in southern California.

By Admin at 7 Jan 2016

The FDA granted accelerated approval for Darzalex, which is a first-in-class immunotherapy treatment which works by helping your immune-system cells attack cancer cells. Darzalex is approved for patients who have received at least three prior treatments for multiple myeloma, meaning the disease has become resistant to the other treatments or has progressed within a short period of time after the last treatment.